Differences In Creatinine Levels And Reticulocyte Values In CKD Patients Undergoing Epo And Non-Epo Therapy

Authors

  • Thomas Tandi Manu Poltekkes Kemenkes Mataram, Indonesia
  • Hikmatul Lailli Poltekkes Kemenkes Mataram, Indonesia
  • I Wayan Getas Poltekkes Kemenkes Mataram, Indonesia

Keywords:

Creatinine ErythropoiettinReticulocytes

Abstract

Chronic kidney disease (CKD) is a condition of progressive and irreversible decline in kidney function. One of the main complications of CKD is anemia, caused by decreased erythropoietin (Epo) production by the kidneys. Epodi therapy is used to stimulate red blood cell production. Reticulocyte counts are used as an indicator of erythropoietic activity, while creatinine levels reflect the degree of kidney damage To determine the differences in creatinine levels and reticulocyte values between CKD patients undergoing Epo and non-Epo therapy.This study was a quantitative cross-sectional study. The sample consisted of 60 CKD patients, divided into two groups: 30 patients with Epo therapy and 30 patients without Epo therapy. Data were collected through medical records and analyzed using the independent T-test. The average creatinine level in the Epo group was 3.96 mg/dL, while in the Non Epo group it was 1.83 mg/dL. The average reticulocyte value in the Epo group was 0.64%, while in the Non Epo group it was 1.49%. The results of the independent T test statistical test obtained a P value of creatinine levels of 0.000_<0.05 while in the reticulocyte value obtained a P value of 0.002_<0.05. There are differences in creatinine levels and reticulocyte values in CKD patients undergoing EPO and non-EPO therapy

References

Indeswari, I. (2022). Gambaran Kadar Kreatinin Pada Peminum Minuman Beralkohol dii Desa Adat Beringkit. (Doctoral dissertation, Poltekkes Kemenkes Denpasar Jurusan Teknologi Laboratorium Medis 2022).

Jiwantoro, Y. A. (2023). Buku Ajar Metode Penelitian Dan Statistik (Untuk Teknologi LaboratoriumMedis). Trans Info Media.

Kallenbach, J. Z. (2020).Review of hemodialysis for nurses and dialysis personnel. Elsevier Health Sciences.

KDIGO. (2012). Clinical practice guideline for the evaluation and management of chronic kidney disease.Kidney International Supplements, 3(1), 1–150.

Locatelli, F., Bárány, P., Covic, A., De Francisco, A., Del Vecchio, L., Goldsmith, D., Horl, W. H., London, G., Vanholder, R., & Wiecek, A. (2004). Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrology Dialysis Transplantation, 24(2), 348–354.

Macdougall, I. C., Bircher, A. J., Eckardt, K. U., Obrador, G. T., Pollock, C. A., Stenvinkel, P., Swinkels, D. W., & Wanner, C. (2014). Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney International, 89(1), 28–39.

Morton, P., Fontaine, D., Hudak, C., & Gallo, B. (2012).Critical care nursing: A holistic approach. Lippincott Williams & Wilkins.

Padma, W. S., Arjani, S. dan Jirna, I. N. 2017. ‘Gambaran Kadar Kreatinin Serum Pada Penderita Diabetes Mellitus Tipe 2 di Rumah Sakit Umum Pusat Sanglah Denpasar.’ Karya Tulis: Poltekkes Denpasar, 5(6), Pp. 107–117.

Pranandari, R., & Supadmi, W. (2015). Faktor risiko gagal ginjal kronik di unit hemodialisis RSUD Panembahan Senopati Bantul.Jurnal Farmasi Sains dan Komunitas, 12(2), 92–97.

Price. 2005. Patofisiologi Konsep Klinis Proses-Proses Penyakit. Jakarta : EGC

Puspita,R.C.,Widiathi,R.I.,&Karsanto,R.M.N.(2022).Hubungan Kadar Kreatinin dengan Klorida pada Pasien Gagal Ginjal Kronik di RSUD Dr. Moewardi Surakarta. Conference on Innovation in Health, Accounting and ManagementSciences(CIHAMS),2,54–58.

Downloads

Published

2026-06-14

How to Cite

Manu, T. T., Lailli, H., & Getas, I. W. (2026). Differences In Creatinine Levels And Reticulocyte Values In CKD Patients Undergoing Epo And Non-Epo Therapy. Jurnal Analis Medika Biosains (JAMBS), 13(01), 42–46. Retrieved from https://jambs.poltekkes-mataram.ac.id/index.php/home/article/view/570

Issue

Vol. 13 No. 01 (2026): JURNAL ANALIS MEDIKA BIOSAINS (JAMBS)

Section

Articles

Citation Check

License

Copyright (c) 2026 Jurnal Analis Medika Biosains (JAMBS)

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

The copyright to this article is transferred to Jurnal Analis Medika Biosains (JAMBS) if and when the article is accepted for publication.

 

Creative Commons License
Jurnal Analis Medika Biosains (JAMBS) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.